Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

Marwan G. Fakih, MD, and Atif Hussein, MD, MMM, FACP, introduce themselves and give an overview of metastatic colorectal cancer (mCRC).

Comprehensive insights on the stratification, diagnosis, and treatment of patients with metastatic colorectal cancer.

A brief overview of treatment options available for patients with colorectal cancer prior to the SUNLIGHT study.

Marwan G. Fakih, MD, reviews the study design for the SUNLIGHT clinical trial investigating trifluridine-tipiracil plus bevacizumab in patients with refractory metastatic CRC.

A comprehensive review of outcome data from the SUNLIGHT clinical trial in patients with refractory metastatic colorectal cancer.

Experts on colorectal cancer provide their key takeaways from the results from the SUNLIGHT study.

Colorectal cancer specialists discuss the effect of the SUNLIGHT trial data on the overall treatment and research landscapes.

Marwan G. Fakih, MD, and Atif Hussein, MD, MMM, FACP, conclude their discussion with advice for clinicians treating patients with metastatic colorectal cancer.